Searching for novel antagonists of adenosine A1 receptors among azolo[1,5-a]pyrimidine nitro derivatives
Introduction: Ligands of adenosine A1Rs are potential candidates for the development of drugs for the treatment of paroxysmal supraventricular tachycardia, angina pectoris, hypertriglyceridemia, type 2 diabetes mellitus, neuropathic pain, and heart failure. At the same time, there is a deficiency of...
Main Authors: | Dmitry S. Yakovlev, Pavel M. Vassiliev, Yana V. Agatsarskaya, Anastasia A. Brigadirova, Kira T. Sultanova, Maria O. Skripka, Alexander A. Spasov, Konstantin V. Savateev, Vladimir L. Rusinov, Dmitriy V. Maltsev |
---|---|
Format: | Article |
Language: | English |
Published: |
Belgorod National Research University
2022-06-01
|
Series: | Research Results in Pharmacology |
Online Access: | https://rrpharmacology.ru/article/77854/download/pdf/ |
Similar Items
-
Azolo[1,5-<i>a</i>]pyrimidines and Their Condensed Analogs with Anticoagulant Activity
by: Konstantin V. Savateev, et al.
Published: (2022-01-01) -
Discovery of Nitro-azolo[1,5-<i>a</i>]pyrimidines with Anti-Inflammatory and Protective Activity against LPS-Induced Acute Lung Injury
by: Alexander Spasov, et al.
Published: (2022-04-01) -
A New Family of Fused Azolo[1,5‑a]pteridines and Azolo[5,1‑b]purines
by: Denis A. Gazizov, et al.
Published: (2020-07-01) -
2-Furyl-6-nitro-1,2,4-triazolo [1,5-<i>a</i>]pyrimidin-7-one
by: Victor V. Fedotov, et al.
Published: (2023-01-01) -
Screening of anxiolytic properties and analysis of structure-activity relationship of new derivatives of 6-(4-methoxy)-7H-[1,2,4]triazolo[3,4-a][2,3]benzodiazepine under the code RD
by: Maria O. Skripka, et al.
Published: (2021-06-01)